Table 2.
Baseline Characteristics Compared with 1-Year A1C
| |
No. of subjects |
Mean 1-year A1C [% (SD)] |
Mean change in A1C from baseline to 1 year [% (SD)] |
|||
|---|---|---|---|---|---|---|
| Baseline characteristic | SAP | MDI | SAP | MDI | SAP | MDI |
| A1C | ||||||
| ≤8 % | 65 | 60 | 7.1 (0.5) | 7.6 (0.7) | −0.7 (0.5) | −0.1 (0.7) |
| 8.1–9% | 85 | 88 | 7.4 (0.7) | 8.0 (0.8) | −1.1 (0.8) | −0.6 (0.8) |
| ≥9.1% | 16 | 15 | 7.7 (0.7) | 9.0 (1.1) | −1.6 (0.7) | −0.3 (1.0) |
| Age at randomization | ||||||
| ≤35 years | 59 | 58 | 7.4 (0.7) | 8.0 (1.0) | −0.7 (0.8) | −0.4 (0.9) |
| 36 – 50 years | 58 | 68 | 7.2 (0.7) | 8.0 (0.9) | −1.1 (0.7) | −0.3 (0.8) |
| ≥51 years | 49 | 37 | 7.3 (0.6) | 7.8 (0.6) | −1.1 (0.7) | −0.4 (0.7) |
| Age at diagnosis | ||||||
| ≤16 years | 61 | 70 | 7.3 (0.7) | 7.8 (0.8) | −0.8 (0.8) | −0.5 (0.7) |
| 17 – 30 years | 57 | 49 | 7.3 (0.6) | 8.0 (1.0) | −1.0 (0.7) | −0.2 (0.9) |
| 31 years | 48 | 44 | 7.3 (0.7) | 7.9 (0.9) | −1.1 (0.7) | −0.3 (0.8) |
| Mean sensor glucose value | ||||||
| ≤160 mg/dL | 50 | 48 | 7.2 (0.6) | 7.7 (0.7) | −1.0 (0.7) | −0.5 (0.7) |
| 161 – 190 mg/dL | 57 | 68 | 7.3 (0.7) | 7.9 (0.9) | −1.0 (0.7) | −0.3 (0.8) |
| ≥191 mg/dL | 59 | 47 | 7.4 (0.7) | 8.1 (0.9) | −1.0 (0.8) | −0.4 (0.9) |
MDI, multiple daily injection; SAP, sensor-augmented pump.